370 related articles for article (PubMed ID: 31673417)
1. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
[TBL] [Abstract][Full Text] [Related]
2. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
4. Impact of patient ancestry on heterogeneity of Sjögren's disease.
Beydon M; Seror R; Le Guern V; Chretien P; Mariette X; Nocturne G
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36878621
[TBL] [Abstract][Full Text] [Related]
5. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
[TBL] [Abstract][Full Text] [Related]
6. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
7. Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren's syndrome: data from a nationwide cohort for Sjögren's syndrome in Korea.
Park Y; Lee J; Koh JH; Sung YK; Lee SS; Choe JY; Shim SC; Kim JM; Kwon SR; Kim HO; Chung SH; Park SH; Kwok SK
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):107-113. PubMed ID: 31376264
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
9. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
ter Borg EJ; Kelder JC
Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
[TBL] [Abstract][Full Text] [Related]
10. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?
Pasoto SG; Natalino RR; Chakkour HP; Viana Vdos S; Bueno C; Leon EP; Vendramini MB; Neto ML; Bonfa E
Rheumatol Int; 2013 May; 33(5):1149-57. PubMed ID: 22955798
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
12. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
13. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
[TBL] [Abstract][Full Text] [Related]
14. Active immunological profile is associated with systemic Sjögren's syndrome.
Martel C; Gondran G; Launay D; Lalloué F; Palat S; Lambert M; Ly K; Loustaud-Ratti V; Bezanahary H; Hachulla E; Jauberteau MO; Vidal E; Hatron PY; Fauchais AL
J Clin Immunol; 2011 Oct; 31(5):840-7. PubMed ID: 21744183
[TBL] [Abstract][Full Text] [Related]
15. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
[TBL] [Abstract][Full Text] [Related]
16. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
17. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
[TBL] [Abstract][Full Text] [Related]
18. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
20. Male patients with primary Sjögren's syndrome: A distinct clinical subgroup?
Park Y; Lee J; Park SH; Kwok SK
Int J Rheum Dis; 2020 Oct; 23(10):1388-1395. PubMed ID: 32918388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]